| Literature DB >> 34196118 |
Kelvin K H Tong1,2, Muhammad Hanif1,2, Sanam Movassaghi1, Matthew P Sullivan1,2,3, James H Lovett4, Katja Hummitzsch5, Tilo Söhnel1, Stephen M F Jamieson2,6, Suresh K Bhargava7, Hugh H Harris4, Christian G Hartinger1,2.
Abstract
We report investigations on the anticancer activity of organometallic [MII/III (η6 -p-cymene/η5 -pentamethylcyclopentadienyl)] (M=Ru, Os, Rh, and Ir) complexes of N-heterocyclic carbenes (NHCs) substituted with a triazolyl moiety. Depending on the precursors, the NHC ligands displayed either mono- or bidentate coordination via the NHC carbon atom or as N,C-donors. The metal complexes were investigated for their stability in aqueous solution, with the interpretation supported by density functional theory calculations, and reactivity to biomolecules. In vitro cytotoxicity studies suggested that the nature of both the metal center and the lipophilicity of the ligand determine the biological properties of this class of compounds. The IrIII complex 5 d bearing a benzimidazole-derived ligand was the most cytotoxic with an IC50 value of 10 μM against NCI-H460 non-small cell lung carcinoma cells. Cell uptake and distribution studies using X-ray fluorescence microscopy revealed localization of 5 d in the cytoplasm of cancer cells.Entities:
Keywords: anticancer activity; biomolecule reactions; bioorganometallics; coordination mode; intracellular distribution
Mesh:
Substances:
Year: 2021 PMID: 34196118 DOI: 10.1002/cmdc.202100311
Source DB: PubMed Journal: ChemMedChem ISSN: 1860-7179 Impact factor: 3.466